News
What a General Practitioner Needs to Know About Gliflozins
The revolutionary benefits of gliflozins have completely changed the perspective on the choice of pharmacotherapy for diabetes. They have attracted not only diabetologists but also cardiologists and nephrologists after the favorable effects of this group of drugs on heart failure and renal functions were demonstrated even in patients without diabetes. Dapagliflozin and empagliflozin were subsequently included in recommendations for the treatment of heart failure regardless of the presence of diabetes. Dapagliflozin has also been approved for…
Results of Long-Term Follow-Up of Patients with Prostate Adenocarcinoma After Radiotherapy with Short-Term Androgen Deprivation
Adding short-term androgen deprivation to radiotherapy improved overall survival, disease-specific…
Longer survival without liver transplant in patients with PBC treated with OCA?
Obeticholic acid (OCA) is a second-line treatment for patients with primary biliary cholangitis…
Dressing Solutions for Better Wound Care
Although wounds at different stages of healing require different types of treatment, the essential…
Care of Surgical Wounds and Choice of Dressings − Main Findings of the Latest International Expert Consensus
In December 2022, Wounds International published a summary of consensus outputs from six…
Impact of Comorbidities on the Efficacy of Ceftaroline Fosamil in Complicated Skin and Soft Tissue Infections − Pooled Analysis of 3 Studies
In 3 randomized Phase III studies, ceftaroline fosamil demonstrated non-inferiority in treating…
Extract of Medical Cannabis Now Available for Czech Patients. What Benefits Does It Bring?
At the end of 2022, a new drug based on cannabis extract Naxiva Panaxol by Neuraxpharm was approved…
Relationship Between Mortality and Use of Statins or RAAS Inhibitors After Aortic Valve Replacement
The impact of prescribed medication after transcatheter aortic valve replacement (TAVR) has not…
Efficacy and Safety of Dupilumab in the Treatment of Severe Asthma Insufficiently Controlled by Standard Therapy – Current Clinical Practice Data
If severe bronchial asthma with type 2 inflammation is insufficiently controlled by combined…
Neuraxpharm Introduces a New Form of Medical Cannabis
Since November 2022, a new medication containing an active full-spectrum cannabis extract – Naxiva…
Conferences
News from the world of medicine
All conferences
Popular this week
- Multiple system atrophy
- Intermittent Fasting May Carry Significant Health Risks
- How Compassion Fatigue Threatens Doctors and Other Healthcare Workers
- Tuberous Sclerosis
- Modern approaches enhancing the efficiency of antibiotic therapy in hospital practice